🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Spencer C. Behr

University of California, San Francisco

ORCID: 0000-0001-9400-0543

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.”.

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.377

N/A

5.8DataRank · unranked

144 citations

Qian Shi, Jeffrey P. Meyers, Joseph M. Herman, Michael Choung, Brian M. Wolpin +13 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

MR-Based Attenuation Correction for Brain PET Using 3-D Cycle-Consistent Adversarial Network

IEEE Transactions on Radiation and Plasma Medical Sciences(2020)10.1109/trpms.2020.3006844

N/A

0.564DataRank · unranked

42 citations

Jaewon Yang, Peder E. Z. Larson, Spencer C. Behr, Thomas A. Hope, Youngho Seo +2 more

Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS -driven tumors

The Journal of Experimental Medicine(2021)10.1084/jem.20210739

N/A

0.520DataRank · unranked

31 citations

Ryan K. Muir, Ryan L. Gonciarz, Adam B. Olshen, Iwei Yeh, Byron Hann +8 more

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0.500DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2340

N/A

0DataRank · unranked

1 citations

T. Zemla, Susan M. Geyer, Jonathan Strosberg, Þorvarður R. Hálfdánarson, Nikolaos A. Trikalinos +13 more

Added Value of Whole-Body Diffusion-Weighted Imaging in Patients Undergoing Prostate-Specific Membrane Antigen Positron Emission Tomography

Journal of Clinical Medicine(2025)10.3390/jcm14061833

N/A

0DataRank · unranked

1 citations

Spencer C. Behr, Fei Jiang, Yingbing Wang, Sina Houshmand, Thomas A. Hope +1 more

Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.242180

N/A

0DataRank · unranked

117 citations

Justin Ferdinandus, Johannes Czernin, Matthias Eiber, Robert R. Flavell, Spencer C. Behr +13 more

705 Immunosuppressive CD14 + monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0705

N/A

0DataRank · unranked

0 citations

Bridget P. Keenan, Bryan Le, Quincy Harris, J.J. Chen, Matthew D. Clark +12 more

CT-less Direct Correction of Attenuation and Scatter in the Image Space Using Deep Learning for Whole-Body FDG PET: Potential Benefits and Pitfalls

Radiology Artificial Intelligence(2020)10.1148/ryai.2020200137

N/A

0DataRank · unranked

56 citations

Jae Ho Sohn, Spencer C. Behr, G.T. Gullberg, Youngho Seo, Jaewon Yang

Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC)

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.12.088971

N/A

0DataRank · unranked

2 citations

Ryan K. Muir, Ryan L. Gonciarz, Adam B. Olshen, Iwei Yeh, Byron Hann +8 more

Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.444

N/A

0DataRank · unranked

9 citations

Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, Faaiz Ibrahim, M. Pollak +8 more

The relationships between patellofemoral bone remodeling, cartilage composition, and vertical loading rate: PET/MRI in isolated patellofemoral osteoarthritis

Osteoarthritis and Cartilage(2024)10.1016/j.joca.2024.09.001

N/A

0DataRank · unranked

12 citations

Eric Hammond, Ngarmsrikam Chotigar, Zehra Akkaya, Fei Jiang, Emma Bahroos +7 more